REGULATORY

First Drug Delisting in Simplified Process Slated for March-End 2026: MHLW

September 10, 2024

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

The first batch of drugs that will go through Japan’s new simplified delisting process will be removed from the NHI price list at the end of March 2026, according to the Ministry of Health, Labor and Welfare (MHLW). The MHLW…

To read the full story

Japan to Delete 16 Drugs from NHI Price List under New Streamlined Process
June 19, 2025
MHLW Announces Simplified New Process for Drug Delisting
August 19, 2024

REGULATORY

LDP Wins Landslide Victory in Lower House Election; Ex-Lawmakers Return as Centrists Routed
February 9, 2026
MHLW Panel Deems 10 “Drug Loss” Products as High-Need, to Seek Development
February 9, 2026
MHLW to Allow OTC Drugs to Match Prescription Doses under Specific Conditions
February 5, 2026
Japan Launches Biotechnology Working Group, Roadmap Draft Due in April
February 4, 2026
Japan Panel Backs Nonprescription Switch of Second Emergency Contraceptive
February 4, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Is Calling for an Abolition the Right Play? Rethinking Japan’s FY2027 Off-Year Drug Price Revision

By Ken Yoshino

Japan’s health and finance ministers agreed late last year to go ahead with an “off-year” drug price revision in FY2027,…

COLUMN

AI in Healthcare Hiring: Leveling the Playing Field & Unlocking Human Potential

By Philip Carrigan

The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…